Results 11 to 20 of about 11,794,837 (186)

Large-cell Neuroendocrine Carcinoma of the Cervix [PDF]

Rare Tumors, 2012
Large cell neuroendocrine carcinoma (LCNEC) of the uterine cervix is a rare and aggressive malignancy with poor prognosis even in its early stage, despite multimodality treatment strategy. Here, we report a case of a woman with clinical polypoid stage IB LCNEC of the cervix, which was detected in her 6-week postpartum checkup.
Arkadiusz Z. Dudek, Alexander M. Truskinovsky, Ming Chi, Benyam Yoseph   +3 more
openaire   +4 more sources

Pulmonary Combined Large Cell Neuroendocrine Carcinoma [PDF]

Pathology and Oncology Research, 2022
Pulmonary combined large-cell neuroendocrine carcinoma (CLCNEC) is a rare neuroendocrine tumor pertained to lung large cell neuroendocrine carcinoma (LCNEC) with aggressive behavior and poor prognosis generally.
Meihui Li, Meihui Li, Meihui Li, Meihui Li, Lan Yang, Lan Yang, Lan Yang, Hongyang Lu, Hongyang Lu, Hongyang Lu   +9 more
doaj   +2 more sources

Large Cell Neuroendocrine Carcinoma of Gallbladder: A Case Report

Journal of Nepal Medical Association
Large cell neuroendocrine carcinoma of the gallbladder is an extremely rare tumour with aggressive behaviour and a bad prognosis. Here, we report a case of a 65-year-old lady suspected of carcinoma of the gallbladder and underwent extended ...
Dhruba Narayan Sah, Oshan Shrestha
doaj   +2 more sources

Large cell neuroendocrine carcinoma of the kidney with cardiac metastasis: a case report [PDF]

Journal of Medical Case Reports, 2017
Background Primary large cell neuroendocrine carcinoma of the kidney is a rare and generally very aggressive disease. We present a case of a patient with primary large cell neuroendocrine carcinoma of the kidney with cardiac metastasis. Case presentation
Moeka Shimbori, Kimito Osaka, Takashi Kawahara, Ryo Kasahara, Sayuki Kawabata, Kazuhide Makiyama, Keiichi Kondo, Noboru Nakaigawa, Shoji Yamanaka, Masahiro Yao   +9 more
doaj   +2 more sources

Treatment of lung large cell neuroendocrine carcinoma [PDF]

Tumor Biology, 2016
Lung large cell neuroendocrine carcinoma (L-LCNEC) is a rare, aggressive, and difficult-to-treat tumor. It is classified as a neuroendocrine subtype of large cell lung carcinoma (LCLC) belonging to the non-small cell lung cancer (NSCLC) group, but it is also included in the neuroendocrine tumor (NET) group.
Lo Russo, Giuseppe, Pusceddu, Sara, Proto, Claudia, Macerelli, Marianna, Signorelli, Diego, Vitali, Milena, Ganzinelli, Monica, Gallucci, Rosaria, Zilembo, Nicoletta, Platania, Marco, Buzzoni, Roberto, De Braud, Filippo, Garassino, Marina Chiara   +12 more
openaire   +5 more sources

Mixed Small Cell and Large Cell Neuroendocrine Carcinoma of the Endometrium

Philippine Journal of Pathology, 2021
Neuroendocrine carcinoma (NEC) of the endometrium is a rare, aggressive subtype of endometrial cancer.  We report a 61-year-old female with a history of breast cancer, s/p modified radical mastectomy, chemotherapy, radiotherapy and hormonal (tamoxifen ...
Joshua Uyboco, Mary Anne Cruz, Maria Concepcion Cenizal, Jeffrey So, Maximino Bello, Jose Moran   +5 more
doaj   +2 more sources

Large cell neuroendocrine carcinoma (LCNEC) of the urinary bladder: a case report

Diagnostic Pathology, 2013
Neuroendocrine carcinoma of the urinary bladder is a rare entity, accounting less then 1% of urinary bladder malignancies. The vast majority of the neuroendocrine carcinoma of the urinary bladder is represented by small cell neuroendocrine carcinoma ...
Colarossi Cristina, Pino Piero, Giuffrida Dario, Aiello Eleonora, Costanzo Rosario, Martinetti Daniela, Memeo Lorenzo   +6 more
doaj   +2 more sources

Large Cell Neuroendocrine Carcinoma of the Uterine Cervix Associated with Adenocarcinoma [PDF]

Taiwanese Journal of Obstetrics & Gynecology, 2007
Objective: Large cell neuroendocrine carcinoma (LCNEC) is a rare and aggressive cervical neoplasm. In the present study, we present a 45-year-old woman with large cell neuroendocrine uterine cervical carcinoma with coexisting adenocarcinoma. Case Report:
Ma-Lee Ko, Cherng-Jye Jeng, Shih-Hung Huang, Jenta Shen, Su-Chee Chen, Chii-Ruey Tzeng   +5 more
doaj   +2 more sources

Expression studies on PPARγ in pancreatic neuroendocrine tumours [PDF]

, 2010
MDPancreatic NETs occur with an annual incidence of around 5 per 1,000,000 population per year, with survival rates of between 30 – 97% at 5 years depending on the tumour subtype.
Hanson, Matthew Richard
core   +4 more sources

Differences in Characteristics and Outcomes Between Large-Cell Neuroendocrine Carcinoma of the Ovary and High-Grade Serous Ovarian Cancer: A Retrospective Observational Cohort Study

Frontiers in Oncology, 2022
BackgroundOwing to its extremely low incidence and the paucity of relevant reports, there is currently no recognized first-line treatment strategy for ovarian large-cell neuroendocrine carcinoma, and there are no statistics related to prognosis derived ...
Li Pang, Zhiqiang Guo
doaj   +1 more source